The FDA’s Project Optimus targets cancer drug dosages and toxicity

When doctors began using the drug sotorasib in 2021, with high expectations for its innovative approach to fighting lung cancer, retired medical technician Don Crosslin was one of the first beneficiaries. Crosslin started taking the drug in July. His tumors shrank, then stabilized.

But while the drug helped him stay alive, its side effects narrowed the boundaries of his life. “My appetite is minimal. I am very weak. I walk my dogs and move around a little, but I haven’t been able to play golf since last July,” said Crosslin, 76, who has stage 4 lung cancer and lives in Ocala, Fla. .

News Source :
Gn Health

Back to top button